BioForce Nanosciences Holdings, Inc.
BFNH · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $20,448 | $15,085 | $12,899 | $9,996 |
| - Cash | $1 | $1 | $14 | $1 |
| + Debt | $0 | $57 | $42 | $274 |
| Enterprise Value | $20,447 | $15,141 | $12,927 | $10,270 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$116 | -$123 | -$133 | -$123 |
| % Margin | – | – | – | – |
| Net Income | -$116 | -$123 | -$935 | -$123 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.004 | -0.029 | -0.004 |
| % Growth | 5.4% | 87.2% | -590.5% | – |
| Operating Cash Flow | -$25 | -$28 | -$15 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$25 | -$28 | -$15 | -$15 |